Graphene oxide based heparin-mimicking and hemocompatible polymeric hydrogels for versatile biomedical applications

Studies on the design of heparin and heparin-mimicking polymer based hydrogels are of tremendous interest and are fuelled by diverse emerging biomedical applications, such as antithrombogenic materials, growth factor carriers, and scaffolds for tissue engineering and regeneration medicine. In this study, inspired by the recent developments of heparin-based hydrogels, graphene oxide (GO) based heparin-mimicking hydrogels with hemocompatibility and versatile properties were prepared via free radical copolymerization, and poly(ethylene glycol) methyl ether methacrylate (PEGMA) and 2-hydroxyethyl methacrylate (HEMA) hydrogels were used as the control samples. The GO based heparin-mimicking polymeric hydrogels exhibited interconnected structures with thin pore walls and high porosity. Because of the increased ionization and electrostatic repulsion of sodium styrene sulfonate (SSNa) segments, the swelling ratios of the SSNa added hydrogels were dramatically increased; after incorporating flexible GO nanosheets, as the 3D skeleton of the hydrogels, the swelling ability was further increased. In addition, the GO based heparin-mimicking hydrogels showed superior red blood cell compatibility, anti-platelet adhesion ability and anticoagulant ability. Furthermore, drug release data indicated that the GO based heparin-mimicking hydrogels had high drug loading ability and prolonged drug releasing ability; the antibacterial tests showed coincident results with large inhibition zones and long effective periods. Due to the integration of blood compatibility, drug loading and releasing abilities, as well as an excellent ability for the removal of toxic molecules, the GO based heparin-mimicking hydrogels can be used for versatile biomedical applications.